228 related articles for article (PubMed ID: 36013579)
21. A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma.
Rattenberry E; Vialard L; Yeung A; Bair H; McKay K; Jafri M; Canham N; Cole TR; Denes J; Hodgson SV; Irving R; Izatt L; Korbonits M; Kumar AV; Lalloo F; Morrison PJ; Woodward ER; Macdonald F; Wallis Y; Maher ER
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1248-56. PubMed ID: 23666964
[TBL] [Abstract][Full Text] [Related]
22. Genetic testing in pheochromocytoma or functional paraganglioma.
Amar L; Bertherat J; Baudin E; Ajzenberg C; Bressac-de Paillerets B; Chabre O; Chamontin B; Delemer B; Giraud S; Murat A; Niccoli-Sire P; Richard S; Rohmer V; Sadoul JL; Strompf L; Schlumberger M; Bertagna X; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
J Clin Oncol; 2005 Dec; 23(34):8812-8. PubMed ID: 16314641
[TBL] [Abstract][Full Text] [Related]
23. Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance.
Gómez AM; Soares DC; Costa AAB; Pereira DP; Achatz MI; Formiga MN
Arch Endocrinol Metab; 2019 Jul; 63(4):369-375. PubMed ID: 31365623
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden.
Muth A; Abel F; Jansson S; Nilsson O; Ahlman H; Wängberg B
World J Surg; 2012 Jun; 36(6):1389-94. PubMed ID: 22270996
[TBL] [Abstract][Full Text] [Related]
25. Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.
Armaiz-Pena G; Flores SK; Cheng ZM; Zhang X; Esquivel E; Poullard N; Vaidyanathan A; Liu Q; Michalek J; Santillan-Gomez AA; Liss M; Ahmadi S; Katselnik D; Maldonado E; Salgado SA; Jimenez C; Fishbein L; Hamidi O; Else T; Lechan R; Tischler AS; Benn DE; Dwight T; Clifton-Bligh R; Sanso G; Barontini M; Vincent D; Aronin N; Biondi B; Koops M; Bowhay-Carnes E; Gimenez-Roqueplo AP; Alvarez-Eslava A; Bruder JM; Kitano M; Burnichon N; Ding Y; Dahia PLM
J Clin Endocrinol Metab; 2021 Jan; 106(1):e350-e364. PubMed ID: 33051659
[TBL] [Abstract][Full Text] [Related]
26. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
[TBL] [Abstract][Full Text] [Related]
27. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
28. Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma.
Seo SH; Kim JH; Kim MJ; Cho SI; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW
Endocrinol Metab (Seoul); 2020 Dec; 35(4):909-917. PubMed ID: 33397043
[TBL] [Abstract][Full Text] [Related]
29. Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.
Pipitprapat W; Pattanaprateep O; Iemwimangsa N; Sensorn I; Panthan B; Jiaranai P; Chantratita W; Sorapipatcharoen K; Poomthavorn P; Mahachoklertwattana P; Sura T; Tunteeratum A; Srichan K; Sriphrapradang C
Ann Med; 2021 Dec; 53(1):1243-1255. PubMed ID: 34309460
[TBL] [Abstract][Full Text] [Related]
30. MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours.
Crona J; Maharjan R; Delgado Verdugo A; Stålberg P; Granberg D; Hellman P; Björklund P
Fam Cancer; 2014 Mar; 13(1):121-5. PubMed ID: 23743562
[TBL] [Abstract][Full Text] [Related]
31. Universal genetic screening uncovers a novel presentation of an SDHAF2 mutation.
Casey R; Garrahy A; Tuthill A; O'Halloran D; Joyce C; Casey MB; O'Shea P; Bell M
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1392-6. PubMed ID: 24712571
[TBL] [Abstract][Full Text] [Related]
32. Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma.
Albattal S; Alswailem M; Moria Y; Al-Hindi H; Dasouki M; Abouelhoda M; Alkhail HA; Alsuhaibani E; Alzahrani AS
Oncotarget; 2019 Oct; 10(57):5919-5931. PubMed ID: 31666924
[TBL] [Abstract][Full Text] [Related]
33. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
[TBL] [Abstract][Full Text] [Related]
34. Routine genetic screening with a multi-gene panel in patients with pheochromocytomas.
Sbardella E; Cranston T; Isidori AM; Shine B; Pal A; Jafar-Mohammadi B; Sadler G; Mihai R; Grossman AB
Endocrine; 2018 Jan; 59(1):175-182. PubMed ID: 28477304
[TBL] [Abstract][Full Text] [Related]
35. [Hereditary pheochromocytoma-associated syndromes. Part 1].
Yukina MY; Troshina EA; Beltsevich DG
Ter Arkh; 2015; 87(9):102-105. PubMed ID: 26591561
[TBL] [Abstract][Full Text] [Related]
36. Germline genetic variants in pheochromocytoma/paraganglioma: single-center experience.
Lima JV; Scalissi NM; de Oliveira KC; Lindsey SC; Olivati C; Ferreira EN; Kater CE
Endocr Oncol; 2023 Jan; 3(1):e220091. PubMed ID: 37529773
[TBL] [Abstract][Full Text] [Related]
37. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.
Burnichon N; Vescovo L; Amar L; Libé R; de Reynies A; Venisse A; Jouanno E; Laurendeau I; Parfait B; Bertherat J; Plouin PF; Jeunemaitre X; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2011 Oct; 20(20):3974-85. PubMed ID: 21784903
[TBL] [Abstract][Full Text] [Related]
38. Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma.
Galan SR; Kann PH
Clin Endocrinol (Oxf); 2013 Feb; 78(2):165-75. PubMed ID: 23061808
[TBL] [Abstract][Full Text] [Related]
39. A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma.
Scollo C; Russo M; De Gregorio L; Terranova R; Mangione E; Castoro C; Squatrito S; Pellegriti G
Endocr J; 2016; 63(1):87-91. PubMed ID: 26497911
[TBL] [Abstract][Full Text] [Related]
40. A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2
Pang Y; Gupta G; Yang C; Wang H; Huynh TT; Abdullaev Z; Pack SD; Percy MJ; Lappin TRJ; Zhuang Z; Pacak K
BMC Cancer; 2018 Mar; 18(1):286. PubMed ID: 29534684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]